CVS Health
CVS
1,549 hedge funds and large institutions have $68.3B invested in CVS Health in 2016 Q4 according to their latest regulatory filings, with 171 funds opening new positions, 547 increasing their positions, 745 reducing their positions, and 165 closing their positions.
4% more first-time investments, than exits
New positions opened: 171 | Existing positions closed: 165
1% less funds holding
Funds holding: 1,565 → 1,549 (-16)
1.31% less ownership
Funds ownership: 82.5% → 81.18% (-1.3%)
13% less call options, than puts
Call options by funds: $774M | Put options by funds: $884M
13% less capital invested
Capital invested by funds: $78.3B → $68.3B (-$9.92B)
27% less repeat investments, than reductions
Existing positions increased: 547 | Existing positions reduced: 745
39% less funds holding in top 10
Funds holding in top 10: 136 → 83 (-53)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$743M |
| 2 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
+$432M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$339M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$292M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$221M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$955M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$555M |
| 3 |
Morgan Stanley
New York
|
-$474M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$406M |
| 5 |
D.E. Shaw & Co
New York
|
-$391M |
CVS Hedge Fund Activity: Q4 2016 in Review
1,549 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2016, worth a combined $68.3B — down 13% from $78.3B a quarter earlier.
Buyers outnumbered sellers: 171 funds opened new CVS positions and 165 closed out — a net gain of 6 holders — while 547 added to existing stakes and 745 trimmed.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $743M. The largest seller was Fidelity Investments, cutting an estimated $955M.
- 1,549 institutional investors held CVS Health (CVS) as of Q4 2016, down from 1,565 in Q3 2016.
- Funds reported $68.3B of CVS Health stock for Q4 2016, down 13% quarter-over-quarter.
- 171 funds opened new CVS Health positions in Q4 2016 and 165 closed out, a net change of +6 holders.
- The largest CVS Health buyer in Q4 2016 was Barrow, Hanley, Mewhinney & Strauss, an estimated $743M added.
- The largest CVS Health seller in Q4 2016 was Fidelity Investments, an estimated $955M sold.
Based on aggregated 13F filings for Q4 2016.